We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+2.28%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$38.1B
AUM Growth
Cap. Flow
+$38.4B
Cap. Flow %
100.8%
Top 10 Hldgs %
11.4%
Holding
2,756
New
2,750
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$671M
2
MCD icon
McDonald's
MCD
+$636M
3
TSM icon
TSMC
TSM
+$515M
4
NVO
Novo Nordisk
NVO
+$465M
5
CL icon
Colgate-Palmolive
CL
+$458M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 14.45%
2 Healthcare 11.94%
3 Consumer Discretionary 11.58%
4 Consumer Staples 10.68%
5 Financials 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RBBN icon
1451
Ribbon Communications
RBBN
$386M
$2.56M 0.01%
+170,409
New +$2.27M
CFFI icon
1452
C&F Financial
CFFI
$275M
$2.56M 0.01%
+45,978
New +$2.1M
TNAV
1453
DELISTED
Telenav Inc.
TNAV
$2.55M 0.01%
+487,314
New +$2.68M
BEAV
1454
DELISTED
B/E Aerospace Inc
BEAV
$2.54M 0.01%
+55,663
New +$2.51M
MAXY
1455
DELISTED
MAXYGEN INC
MAXY
$2.54M 0.01%
+1,022,768
New +$2.48M
CENTA icon
1456
Central Garden & Pet Co Class A
CENTA
$2.43B
$2.54M 0.01%
+459,250
New +$2.96M
CTAS icon
1457
Cintas
CTAS
$86.6B
$2.53M 0.01%
+222,400
New +$2.51M
GPRE icon
1458
Green Plains
GPRE
$1.15B
$2.52M 0.01%
+189,543
New +$2.52M
CTRX
1459
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
$2.52M 0.01%
+51,770
New +$2.7M
SAPE
1460
DELISTED
SAPIENT CORP
SAPE
$2.52M 0.01%
+193,147
New +$2.33M
DENN
1461
DELISTED
Denny's
DENN
$2.52M 0.01%
+448,100
New +$2.59M
RAX
1462
DELISTED
Rackspace Hosting Inc
RAX
$2.52M 0.01%
+66,400
New +$2.79M
FFKT
1463
DELISTED
Farmers Capital Bank Corp
FFKT
$2.51M 0.01%
+115,900
New +$2.34M
CKP
1464
DELISTED
CHECKPOINT SYSTEMS INC
CKP
$2.49M 0.01%
+175,500
New +$2.23M
CRTX
1465
DELISTED
CORNERSTONE THERAPEUTICS INC
CRTX
$2.48M 0.01%
+310,529
New +$2.62M
XLE icon
1466
State Street Energy Select Sector SPDR ETF
XLE
$39B
$2.48M 0.01%
+63,400
New +$2.51M
PKY
1467
DELISTED
Parkway, Inc.
PKY
$2.48M 0.01%
+148,000
New +$2.64M
IDXG
1468
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$2.48M 0.01%
+5,274
New +$2.39M
OPCH icon
1469
Option Care Health
OPCH
$3.76B
$2.48M 0.01%
+37,538
New +$2.11M
CIR
1470
DELISTED
CIRCOR International, Inc
CIR
$2.48M 0.01%
+48,700
New +$2.34M
WNS
1471
DELISTED
WNS Holdings
WNS
$2.48M 0.01%
+148,300
New +$2.3M
IX icon
1472
ORIX
IX
$42.7B
$2.45M 0.01%
+179,500
New +$2.54M
SRGA
1473
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$2.45M 0.01%
+21,720
New +$2.66M
HCOM
1474
DELISTED
Hawaiian Telcom Holdco, Inc
HCOM
$2.45M 0.01%
+97,300
New +$2.38M
SGI
1475
DELISTED
Silicon Graphics Intl.
SGI
$2.44M 0.01%
+182,032
New +$2.49M

Similar funds

Renaissance Technologies's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Renaissance Technologies, which disclosed 2,756 positions worth $38.1B. Its ten largest holdings account for 11% of the portfolio.

Its largest position is Eli Lilly: 12,326,205 shares worth $605M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, followed by Healthcare and Consumer Discretionary.

  • Renaissance Technologies's largest Q2 2013 buy was Eli Lilly: 12,326,205 shares worth $605M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $38.1B portfolio in Q2 2013.
  • Renaissance Technologies disclosed 2,756 positions in Q2 2013, its first 13F filing on record.

Based on Renaissance Technologies's 13F filing for Q2 2013, filed 12 Aug 2013.